Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Assets (2016 - 2026)

Phibro Animal Health has reported Assets over the past 13 years, most recently at $1.4 billion for Q4 2025.

  • For Q4 2025, Assets rose 9.34% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 9.34%, while the annual FY2025 figure was $1.4 billion, 38.56% up from the prior year.
  • Assets for Q4 2025 was $1.4 billion at Phibro Animal Health, up from $1.4 billion in the prior quarter.
  • Over five years, Assets peaked at $1.4 billion in Q4 2025 and troughed at $805.0 million in Q1 2021.
  • A 5-year average of $1.0 billion and a median of $965.9 million in 2023 define the central range for Assets.
  • Biggest five-year swings in Assets: increased 0.18% in 2024 and later soared 43.39% in 2025.
  • Year by year, Assets stood at $849.0 million in 2021, then grew by 13.3% to $961.8 million in 2022, then grew by 1.13% to $972.7 million in 2023, then surged by 32.16% to $1.3 billion in 2024, then rose by 9.34% to $1.4 billion in 2025.
  • Business Quant data shows Assets for PAHC at $1.4 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q2 2025.